Bicycle Therapeutics (BCYC) Total Liabilities (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Total Liabilities data on file, last reported at $96.3 million in Q2 2026.

• Quarterly Total Liabilities fell 41.0% year-over-year to $96.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $96.3 million (down 41.0% YoY) and the FY2025 annual result came in at $107.6 million, down 34.3% from the prior year.
• Total Liabilities retreated to $96.3 million in Q2 2026, from $98.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $234.1 million in Q2 2023 to a low of $96.3 million in Q2 2026.
• A 5-year average of $158.7 million and a median of $154.4 million in 2025 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2023 — Total Liabilities soared 74.56% — and 2026, when it tumbled 41.0%.
• Tracing BCYC's Total Liabilities over 5 years: stood at $139.8 million in 2022, then jumped by 60.49% to $224.4 million in 2023, then retreated by 27.01% to $163.8 million in 2024, then sank by 34.3% to $107.6 million in 2025, then declined by 10.5% to $96.3 million in 2026.
• The last three Total Liabilities figures came in at $96.3 million (Q2 2026), $98.1 million (Q1 2026), and $107.6 million (Q4 2025), per Business Quant data.